Pennant Investors’s Core Scientific CORZ Stock Holding History

Pennant Investors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6M	Sell	1,110,000 -430,495	-28%	-$7.34M	4.6%	11
2025 Q4	$22.4M	Sell	1,540,495 -285,000	-16%	-$4.97M	5.37%	9
2025 Q3	$32.7M	Buy	1,825,495 +326,495	+22%	+$4.79M	8.81%	3
2025 Q2	$25.6M	Buy	1,499,000 +164,000	+12%	+$1.64M	7.65%	7
2025 Q1	$9.67M	Buy	1,335,000 +705,000	+112%	+$8.02M	2.52%	15
2024 Q4	$8.85M	Sell	630,000 -164,813	-21%	-$2.43M	2.5%	13
2024 Q3	$9.43M	Buy	794,813 +294,813	+59%	+$3.06M	2.69%	13
2024 Q2	$4.65M	Buy	+500,000	New	+$2.55M	1.22%	15

Other funds holding CORZ

Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Pennant Investors's CORZ Position: Q1 2026 in Review

Pennant Investors reduced its Core Scientific (CORZ) stake by 28% in Q1 2026, selling an estimated $7.34M and leaving 1,110,000 shares worth $16.6M. The position accounts for 4.6% of the portfolio, ranked #11.

Pennant Investors first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $32.7M in Q3 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

Pennant Investors held 1,110,000 shares of Core Scientific worth $16.6M as of Q1 2026.
Pennant Investors sold 430,495 Core Scientific shares in Q1 2026, an estimated $7.34M.
Core Scientific made up 4.6% of Pennant Investors's portfolio in Q1 2026, its #11 holding.
Pennant Investors first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
Pennant Investors's Core Scientific position peaked at $32.7M in Q3 2025.
386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Pennant Investors's 13F filing for Q1 2026, filed 15 May 2026.